Innovation Park Basel Area

Innovation Log


The Park Basel Area community is growing – we are delighted to welcome four new startups in April.

With Polyneuron Pharmaceuticals, a spin-off from University of Basel, and the Polish biotech startup Captor Therapeutics, Park Basel Area gains new experts in the field of innovative health-oriented life sciences.

The French biotech startup Algae Natural Switzerland, which aims to contribute to a healthier nutrition with its microalgae, and a recently founded medtech company in stealth mode further expand the startup portfolio.

Algae Natural Switzerland
Algae Natural Switzerland AG provides protein and/or omega-3 rich high-quality microalgae for food and feed applications. The company’s production process for organic microalgae is developed based on a sustainable and circular approach for a successful eco-conception.

Captor Therapeutics
Captor Therapeutics is a Polish biotech company developing drug candidates for the treatment of oncology and chronic inflammation.

Polyneuron Pharmaceuticals
Polyneuron Pharmaceuticals is a spin-off from the University of Basel focusing on the development of a promising new drug class to treat autoimmune disorders.

Medtech company in stealth mode.

Leave a Comment:

«You may also like»

Basel is a hotspot for innovation

Basel is an international hub for innovative companies. This has been found in a ranking of…> Read more

Fully equipped lab spaces at the Switzerland Innovation Park Basel Area

Launching a biotech is a daunting endeavor. Resources – both human and capital - are scarce…> Read more
New residents at Switzerland Innovation Park Basel Area

150 Scientists Working on Life Sciences Innovation

The community at Switzerland Innovation Park Basel Area keeps growing. We are delighted to present our…> Read more